Startups

Pelage

Pelage Pharmaceuticals is developing PP405, a topical regenerative small molecule intended to reactivate dormant hair-follicle stem cells and restore hair growth.

Founded 2018

Team

Daniel GilCEO

Michael JungCo-founder

Investments

$120M2025-10-15	ARCH Venture Partners, GV, Main Street Advisors, Visionary Ventures, YK Bioventures
$120MUnknown date	ARCH Venture Partners, YK Bioventures, Visionary Ventures, Main Street Advisors